Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 4/20 | 0.47 |
| ▸ | KDM2B | Q8NHM5 | 2/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | PRKACA | P17612 | 1/20 | 0.32 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720692 | 0.85 | HRH3 (0.40) | SRD5A2KDM2BHRH3CYP2D6PRKACA | |
| SCHEMBL14721352 | 0.83 | SRD5A2 (0.41) | SRD5A2HRH3MEN1KMT2A | |
| SCHEMBL14720521 | 0.79 | SRD5A2 (0.40) | SRD5A2HRH3 | |
| SCHEMBL14721067 | 0.79 | SRD5A2 (0.42) | SRD5A2KDM2BHRH3CYP2D6 | |
| SCHEMBL14721333 | 0.76 | SRD5A2 (0.52) | SRD5A2HRH3MEN1KMT2A | |
| SCHEMBL14720838 | 0.76 | SRD5A2 (0.44) | SRD5A2KDM2BHRH3CYP2D6TSHR | |
| SCHEMBL14720473 | 0.75 | SRD5A2 (0.48) | SRD5A2HRH3HDAC6 | |
| SCHEMBL14720367 | 0.73 | HRH3 (0.42) | KDM2BHRH3CYP2D6MEN1KMT2A | |
| SCHEMBL14720723 | 0.73 | KDM2B (0.38) | KDM2BHRH3CYP2D6 | |
| SCHEMBL1790109 | 0.73 | HRH3 (0.54) | KDM2BHRH3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |